A bill that would ban the use of mRNA vaccines, including for Covid-19, is on its way to the House floor after passing out of committee in a party-line vote Wednesday.

Vaccines are designed to guard babies, toddlers, and older children against a whole range of serious and potentially deadly ...

The Trump administration’s moves to trim government spending pose a short-term “understated risk” for companies all across ...

All this negativity, however, does open up an opportunity for investors to buy the stock at a discount. Despite being a top ...

A trio of high-octane income stocks -- sporting an average yield of 6.65% -- can fatten investors' pocketbooks in 2025 (and ...

By disparaging public-health methods and discrediting vaccines, the COVID‑19 minimizers cost hundreds of thousands of people ...

Pam Bondi’s office had the opportunity to hold Trump University accountable for its fraudulent practices, which scammed ...

Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...

SARS-CoV-2 risk is lower among children aged younger than 5 who had vs did not have prior infection, regardless of vaccination status.

As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...

US companies are putting up one of their best earnings seasons in three years on the back of robust economic growth. It’s ...

Moderna (MRNA), once a pandemic-era darling, has seen its stock plummet 65% over the past year, battered by fading vaccine ...